Mass Spectrometry Metabolomics Based Biomarkers for Detection of Autism Spectrum Disorder from Patient Blood Samples – IMFAR 2014 [PDF]
Presented at the 2014 International Meeting for Autism Research in Atlanta, Georgia in May 2014.
The diagnosis of autism spectrum disorder (ASD) at the earliest age possible is important for initiating optimally effective intervention. Patients can be reliably diagnosed through behavioral testing at about 2 years of age. However, in the United States, the average age of diagnosis is around 4 years. Using a non-targeted mass spectrometry-based metabolomic analysis of blood plasma, we demonstrated that some features with differential abundance in ASD vs. TD patients (4-6 years old) can be used to derive classification models with 81% accuracy.
Posters & Publications
- The Children’s Autism Metabolome Project (CAMP) was the largest study to date to evaluate the metabolism of childre… https://t.co/QPXCK0ICpV2 days ago
- Which environment is better for the delivery of autism intervention services? Home or an autism research center? Th… https://t.co/n057kPdpU22 days ago
- Though about half of people with autism also have an intellectual disability, a recent meta-analysis of 100s of aut… https://t.co/dDGzFFRDSD2 days ago